IL17A and atrial fibrillation: In patients with atrial fibrillation, it has been shown that colchicine downregulates the activation of IL-17A and renin-angiotensin axes, which may contribute to its anti-fibrotic effect.37 In agreement with these results, we found that colchicine promoted a decline in IL-17A levels.